Takada Mariko, Numano Kayoko, Nakano Masahiko, Yamamoto Akio, Imokawa Genji
Center for Bioscience Research and Education, Utsunomiya University, Tochigi 321-8505, Japan.
Ebisu Ray Clinic, Tokyo 150-0013, Japan.
Int J Mol Sci. 2024 Dec 15;25(24):13453. doi: 10.3390/ijms252413453.
Little is known about the anti-pigmenting effects of skin-whitening agents on solar lentigos (SLs). To characterize the anti-pigmenting effects of a newly designed derivative ascorbyl glucoside-arginine complex (AGAC) on SLs, lotions with or without 28% AGAC were applied twice daily for 24 weeks in a double-blind half-face study of 27 Japanese females with SLs. The pigmentation scores and skin colors of previously selected SLs on the right and left sides of the faces of the subjects were evaluated using a photo-scale, a color difference meter and a Mexameter. Treatment with the test lotion elicited a significant decrease in pigmentation scores at 24 weeks compared to week 0, with a significant decrease in pigmentation scores at 24 weeks compared to the placebo lotion. In the test lotion-treated SLs, the lightness (L) and melanin index (MI) values that reflect the pigmentation level significantly increased and decreased, respectively, at 12 and 24 weeks of treatment compared to week 0. Comparisons of increased L values or decreased MI values between the test and placebo lotion-treated SLs demonstrated that the test lotion-treated SLs had significantly higher increased L or decreased MI values than the placebo lotion-treated SLs both at 12 and 24 weeks of treatment. The sum of our results strongly indicates that AGAC is distinctly effective in ameliorating the hyperpigmentation levels of SLs at a level visibly recognizable by the subjects, without any hypo-pigmenting effects or skin problems.
关于美白剂对日光性雀斑(SLs)的抗色素沉着作用,人们了解甚少。为了表征一种新设计的衍生物抗坏血酸葡糖苷 - 精氨酸复合物(AGAC)对SLs的抗色素沉着作用,在一项针对27名患有SLs的日本女性的双盲半脸研究中,每天两次涂抹含或不含28%AGAC的乳液,持续24周。使用照片量表、色差仪和黑素仪评估受试者面部左右两侧先前选定的SLs的色素沉着评分和皮肤颜色。与第0周相比,使用测试乳液治疗在24周时色素沉着评分显著降低,与安慰剂乳液相比,24周时色素沉着评分也显著降低。在使用测试乳液治疗的SLs中,与第0周相比,反映色素沉着水平的亮度(L)值和黑色素指数(MI)值在治疗12周和24周时分别显著增加和降低。测试乳液和安慰剂乳液治疗的SLs之间L值增加或MI值降低的比较表明,在治疗12周和24周时,测试乳液治疗的SLs的L值增加或MI值降低均显著高于安慰剂乳液治疗的SLs。我们的研究结果有力地表明,AGAC在改善SLs的色素沉着过度水平方面具有明显效果,受试者能够明显识别,且无任何色素减退作用或皮肤问题。